Bahrain Pharmaceuticals and Healthcare Report Q3 2008

  • ID: 655816
  • September 2008
  • Region: Bahrain
  • 66 Pages
  • Business Monitor International
1 of 4


  • Al-Jishi Corporation
  • GlaxoSmithKline
  • Johnson & Johnson
  • Merck & Co
  • Novartis
  • Pfizer
  • MORE

BMI's Bahrain Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Bahrain's pharmaceuticals and healthcare industry.

The Bahraini pharmaceutical market – evenly split between the private and the public spheres – was worth an estimated US$58.3mn in 2007, which is small by both regional and global standards. Although the market is forecast to experience GDP-beating growth, driven by a growing non-communicable disease burden and a continued reliance on imported patented drugs, it remains a marginal target for foreign drugmakers, due to its small size. Nevertheless, its value will grow to a forecast US$75.9mn by 2012, illustrating opportunities for companies which decide to invest in the country and also to take advantage of the growing integration between members of the Gulf Co-operation Council (GCC) states.

In BMI’s Business Environment Rating for the 13 countries of the Middle East and Africa (MEA) region, Bahrain again occupies a third place, finding itself alongside South Africa. On the positive side, Bahrain has the second-best regulatory structure in the region – after the United Arab Emirates READ MORE >

Note: Product cover images may vary from those shown
2 of 4


  • Al-Jishi Corporation
  • GlaxoSmithKline
  • Johnson & Johnson
  • Merck & Co
  • Novartis
  • Pfizer
  • MORE

Executive Summary
Bahrain Pharmaceuticals And Healthcare Industry SWOT
Bahrain Political SWOT
Bahrain Economic SWOT
Bahrain Business Environment SWOT
Pharmaceutical Business Environment Ratings
Table: Middle East And Africa Pharmaceutical Business Environment Ratings For Q308
Limits Of Potential Returns
Risks To Realisation Of Returns
Bahrain – Market Summary
Regulatory Regim
Recent Regulatory Developments
GCC Healthcare Collaboration
Intellectual Property Developments
Pricing And Reimbursement Regime
Free Trade Agreement With The US
Other Free Trade Agreements
Industry Developments
Health Status
Healthcare Sector
Primary, Secondary And Tertiary Healthcare
Table: Departments Of Environmental And Occupational Healthcare
Health Insurance
Table: National Health Insurance Scheme Breakdown
Strategic Healthcare Goals
Investment In And Expansion Of The Healthcare Sector
Pharmaceutical Sector
Pharmaceutical Retail
Research And Development
Table: Intas Biopharmaceuticals Timeline
International Collaboration
Medical Devices
Table: Bahrain’s Medical Device Market, 2006-2012 (US$mn unless otherwise stated)
Industry Forecast Scenario
Overall Market Forecasts
Table: Drug Expenditure And Prescription Market Indicators (US$mn Unless Otherwise Indicated)
Key Growth Factors – Industry
Table: Health Expenditure Forecasts
Key Growth Factors – Macroeconomic
Table: Bahrain Economic Activity
Patented Market Forecast
Table: Prescription Drug Market Forecast (US$mn unless otherwise stated)
Generics Drug Market Forecast
Table: Generics Drug Market Forecasts
OTC Market Forecast
Table: OTC Market Data Forecasts (US$mn unless otherwise stated)
Export/Import Market Forecast
Pharmaceutical Trade Balance, 2006-2012 (US$mn)]
Other Healthcare Data Forecasts
Table: Other Health Indicators
Key Risks To BMI’s Forecast Scenario
Competitive Landscape
Company Monitor
Multinational Companies
Johnson & Johnson
Merck & Co
Indigenous Companies
Bahrain Industrial Pharmaceutical Co (Bidapharm)
Al-Jishi Corporation
Behzad Medical Establishment
Yousuf Mahmood Husain Company
BMI Forecast Modelling
How We Generate Our Pharmaceutical Industry Forecasts
Pharmaceutical Industry
Pharmaceutical Business Environment Ratings Methodology
Ratings Overview
Table: Pharmaceutical Business Environment Indicators
Table: Weighting Of Components

Note: Product cover images may vary from those shown
3 of 4

-Johnson & Johnson
-Merck & Co
-Bahrain Industrial Pharmaceutical Co (Bidapharm)
-Al-Jishi Corporation
-Behzad Medical Establishment
-Yousuf Mahmood Husain Company

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown


  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.


If you have a more general question about our products please try our



Our Clients

  • AB Sciex
  • Eli Lilly and Company
  • B. Braun Melsungen AG
  • Astellas Pharma, Inc.
  • Hologic Inc.
  • Merck & Co., Inc.